E-LIB Suche - Ergebnisse für: Peter Mesenbrink

1

Developing generic templates to shape the future for conduc..:

Gidh-Jain, Madhavi ; Parke, Tom ; König, Franz...
Trials. 25 (2024) 1 - p. , 2024

2

Regulatory Issues of Platform Trials: Learnings from EU‐PEA..:

Nguyen, Quynh Lan ; Hees, Katharina ; Hernandez Penna, Sabina...
Clinical Pharmacology & Therapeutics. 116 (2024) 1 - p. 52-63 , 2024

Link: https://doi.org/10.1002/..

3

MRI BIOMARKERS OF KNEE OSTEOARTHRITIS PROGRESSION: RESULTS ..:

Collins, Jamie E. ; Mesenbrink, Peter ; Jin, Rui...
Osteoarthritis and Cartilage. 32 (2024) - p. S110-S111 , 2024

Link: https://doi.org/10.1016/..

4

Machine learning approaches to enhance diagnosis and stagin..:

McTeer, Matthew ; Applegate, Douglas ; Mesenbrink, Peter...
PLOS ONE. 19 (2024) 2 - p. e0299487 , 2024

Link: https://doi.org/10.1371/..

5

A deep-learning-based model for assessment of autoimmune he..:

Ercan, Caner ; Kordy, Kattayoun ; Knuuttila, Anna...
Virchows Archiv. , 2024

Link: https://doi.org/10.1007/..

6

Lessons for the setting of an international integrated rese..:

Pericàs, Juan M ; de Sena, Elena ; Tacke, Frank...
Journal of Hepatology. 78 (2023) - p. S819 , 2023

Link: https://doi.org/10.1016/..

7

Platform trials to overcome major shortcomings of tradition..:

Pericàs, Juan M. ; Tacke, Frank ; Anstee, Quentin M....
Journal of Hepatology. 78 (2023) 2 - p. 442-447 , 2023

Link: https://doi.org/10.1016/..

8

Designing an exploratory phase 2b platform trial in NASH wi..:

Meyer, Elias Laurin ; Mesenbrink, Peter ; Di Prospero, Nicholas A....
PLOS ONE. 18 (2023) 3 - p. e0281674 , 2023

Link: https://doi.org/10.1371/..

9

On model-based time trend adjustments in platform trials wi..:

Bofill Roig, Marta ; Krotka, Pavla ; Burman, Carl-Fredrik...
BMC Medical Research Methodology. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

10

Longitudinal ALT trajectories are generally stable among pa..:

Fried, Michael ; Munoz, Breda ; Wu, Jamie...
Journal of Hepatology. 77 (2022) - p. S449 , 2022

Link: https://doi.org/10.1016/..

11

Decision rules for identifying combination therapies in ope..:

Meyer, Elias Laurin ; Mesenbrink, Peter ; Dunger‐Baldauf, Cornelia...
Pharmaceutical Statistics. 21 (2022) 3 - p. 671-690 , 2022

Link: https://doi.org/10.1002/..

12

Systematic review of available software for multi-arm multi..:

on behalf of EU-PEARL (EU Patient-cEntric clinicAl tRial pLatforms) Consortium ; Meyer, Elias Laurin ; Mesenbrink, Peter...
Trials. 22 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

13

Predicting advanced fibrosis using non-invasive clinical te..:

Mesenbrink, Peter ; Barritt, A. Sidney ; Loomba, Rohit...
Journal of Hepatology. 73 (2020) - p. S431-S432 , 2020

Link: https://doi.org/10.1016/..

14

The Evolution of Master Protocol Clinical Trial Designs: A ..:

Meyer, Elias Laurin ; Mesenbrink, Peter ; Dunger-Baldauf, Cornelia...
Clinical Therapeutics. 42 (2020) 7 - p. 1330-1360 , 2020

Link: https://doi.org/10.1016/..

15

Clinical Study Design to Assess Both Short- and Long-term E..:

Yuan, Jiacheng ; Mesenbrink, Peter ; Zhou, Jihao...
Therapeutic Innovation & Regulatory Science. 52 (2018) 6 - p. 690-695 , 2018

Link: https://doi.org/10.1177/..